Barr E S & CO Abb Vie Inc. Transaction History

Barr E S & CO

$1.57 Billion
Q3 2024

A detailed history of Barr E S & CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Barr E S & CO holds 3,565 shares of ABBV stock, worth $652,680. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,565

Previous 2,699 32.09%

Holding current value

$652,680

Previous $462,000 52.38%

% of portfolio

0.04%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $141,885 - $172,619	866 Added 32.09%	3,565 $704,000
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $1,547 - $1,807	10 Added 0.37%	2,699 $462,000
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $382,129 - $435,401	-2,391 Reduced 47.07%	2,689 $489,000
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $13,897 - $15,651	101 Added 2.03%	5,080 $787,000
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $80,154 - $92,790	-600 Reduced 10.75%	4,979 $742,000
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $66,255 - $82,450	500 Added 9.84%	5,579 $751,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $9,958 - $11,942	-72 Reduced 1.4%	5,079 $821,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $26,842 - $30,786	-200 Reduced 3.74%	5,151 $691,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $1,181 - $1,495	-11 Reduced 0.21%	5,351 $725,000
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $1,170 - $1,328	11 Added 0.21%	5,362 $578,000
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $79,328 - $88,376	754 Added 16.4%	5,351 $603,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $125,904 - $190,886	-1,952 Reduced 29.81%	4,597 $350,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $27,553 - $34,475	382 Added 6.19%	6,549 $580,000
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $36,135 - $46,189	-550 Reduced 8.19%	6,167 $448,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $42,427 - $49,934	550 Added 8.92%	6,717 $541,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $24,834 - $30,627	319 Added 5.45%	6,167 $569,000
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $17,782 - $19,768	-200 Reduced 3.31%	5,848 $553,000
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $5,463 - $5,990	-61 Reduced 1.0%	6,048 $585,000
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $426,713 - $545,044	6,109	6,109 $543,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barr E S & CO, based on Form 13F filings with the SEC.

News

Stay updated on Barr E S & CO with notifications on news.

Account